FTC News
Most Popular FTC Story
CSL to fight FTC on Talecris merger
Blood plasma company CSL says it's prepared to fight the Federal Trade Commission's decision to block its $3.1 billion acquisition of rival Talecris Biotherapeutics, the Sydney Morning Herald Read more...
Latest Headlines
- June 10, 2009
- May 29, 2009
- March 31, 2008
- December 5, 2007
- January 18, 2007
- July 9, 2006
- June 26, 2006
- April 24, 2006
- March 29, 2006
- March 13, 2006
- November 7, 2005
- November 2, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
